Immunic Inc. buy tamam
Start price
25.03.20
/
50%
€7.50
Target price
04.11.21
€25.00
Performance (%)
17.93%
End price
05.11.21
€8.85
Summary
This prediction ended on 05.11.21 with a price of €8.85. The prediction had a final performance of 17.93%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunic Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by tamam for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) announces positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS).
In the thread Trading Immunic Inc.
Die von tamam gewählte maximale Laufzeit wurde überschritten